Patent · US Active

Rapamycin derivatives

US12091424B2 · kind B2 · utility

1Cited by

16References

23Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Simone BONAZZI · Cambridge, US
Michael Connolly · Salem, US
David Glass · Cambridge, US
Manuel Mihalic · Wyhlen, DE
Andrew W. Patterson · Somerville, US
Silvio Roggo · Muttenz, CH
Tea Shavlakadze · Cambridge, US

Key dates

Filing date	Oct 12, 2021
Grant date	Sep 17, 2024
Priority date	—
Expiry date	Dec 31, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07F9/6561
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The disclosure relates to compounds of formula (I) and pharmaceutically acceptable salts, and compositions thereof, wherein the substituents are as defined herein. Also provided are methods of making compounds of formula (I), and methods involving the compounds or compositions for treating disorders and diseases described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.